Acadia Pharmaceuticals Inc.

Acadia Pharmaceuticals Inc. disclosed a data breach affecting its 'More to Parkinson’s' community. Due to an internal email misconfiguration, a recipient's registered name was sent to another member's email address. Only names were exposed; no medical records or other PII were accessed. The incident was discovered on November 4, 2024, and regulators were notified.

Acadia Pharmaceuticals Inc. experienced a data incident involving the misdelivery of emails to members of its 'More to Parkinson’s' community. Due to an internal error, emails sent between October 24 and November 4, 2024, contained recipient names that did not match the email addresses they were sent to, potentially disclosing the name of one individual to another. Acadia became aware of the incident on November 4, 2024. No medical records or other identifiable information beyond names were disclosed.

Acadia Pharmaceuticals Inc. reported a data breach to the Montana Attorney General. The breach was reported on 2024-12-04. The breach occurred from 10/24/2024 to 10/30/2024.

Acadia Pharmaceuticals Inc. reported a data breach to the Oregon Attorney General. The breach was reported on 2024-12-04. 14,065 individuals were affected.

Acadia Pharmaceuticals Inc reported a data breach to the Indiana Attorney General. The breach occurred on 2024-02-21 and was reported on 2024-05-21. 873 Indiana residents were affected.

Cencora, Inc. notified the California Attorney General of a data breach involving its Lash Group affiliate. On February 21, 2024, Cencora learned that data from its information systems had been exfiltrated. The incident potentially affected personal information including names, addresses, dates of birth, health diagnoses, and medications. Cencora engaged law enforcement and cybersecurity experts, contained the incident, and offered 24 months of credit monitoring to affected individuals.